Pharmaceutical Institute, Section Pharmacology and Toxicology, University of Bonn, Bonn, Germany.
Institute of Experimental Haematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany.
Nat Commun. 2024 Nov 12;15(1):9554. doi: 10.1038/s41467-024-53770-9.
The discovery of Toll-like receptors (TLRs) represented a significant breakthrough that paved the way for the study of host-pathogen interactions in innate immunity. However, there are still major gaps in understanding TLR function, especially regarding the early dynamics of downstream TLR pathways. Here, we present a label-free optical biosensor-based assay as a method for detecting TLR activation in a native and label-free environment and defining the dynamics of TLR pathway activation. This technology is sufficiently sensitive to detect TLR signaling and readily discriminates between different TLR signaling pathways. We define pharmacological modulators of cell surface and endosomal TLRs and downstream signaling molecules and uncover TLR signaling signatures, including potential biased receptor signaling. These findings highlight that optical biosensor assays complement traditional assays that use a single endpoint and have the potential to facilitate the future design of selective drugs targeting TLRs and their downstream effector cascades.
Toll 样受体 (TLR) 的发现是一个重大突破,为研究天然免疫中的宿主-病原体相互作用铺平了道路。然而,对于 TLR 功能的理解仍存在重大空白,特别是对于下游 TLR 途径的早期动力学。在这里,我们提出了一种基于无标记光学生物传感器的测定法,用于在天然和无标记环境中检测 TLR 激活,并定义 TLR 途径激活的动力学。该技术具有足够的灵敏度来检测 TLR 信号,并能轻松区分不同的 TLR 信号通路。我们定义了细胞表面和内体 TLR 及其下游信号分子的药理学调节剂,并揭示了 TLR 信号特征,包括潜在的偏向性受体信号。这些发现表明,光学生物传感器测定法补充了使用单一终点的传统测定法,并有潜力促进未来针对 TLR 及其下游效应级联的选择性药物的设计。